Business Context and Reporting Period
This Form 6-K is filed by pSivida Limited (not Eyepoint, Inc.) for the month of June 2005, with a filing date of June 16, 2005. The registrant is a foreign issuer based in Perth, Western Australia, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of a specific corporate event rather than a financial statement.
Material Changes
The primary material event disclosed is the granting of a Korean Patent for electronic stimulation using the company's BioSiliconTM technology, specifically for "Smart" Orthopaedic products.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the exhibit index regarding the patent grant.
Investor Verification Checklist
- Verify the commercial viability and market potential of the newly granted Korean patent for BioSiliconTM orthopaedic products.
- Confirm the discrepancy between the requested company name (Eyepoint, Inc.) and the actual registrant (pSivida Limited).
- Review subsequent filings for financial impact related to this intellectual property milestone.